Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Who Are The Key Players Shaping The Sacral Nerve Stimulation Devices Market Trends? Key players in the market include Abbott, Medtronic plc, Boston Scientific Corporation, Livanova, Axonics ...

Before the approval of sacral nerve stimulation (SNS), urologists had ... With the introduction of SNS (Medtronic, Inc), a new surgical technique developed by urologists for urologists is now ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Medtronic first sued Axonics in 2019 after it received approval from the Food and Drug Administration for its Axonics r-SNM system, a rechargeable sacral ... for electrical stimulation and a ...

California medical device company Axonics has won its patent infringement trial after Medtronic alleged the company had copied three elements of its sacral neuromodulation technology. The lawsuit ...

our view is that Medtronic’s lawsuit was initiated to stifle competition, limit patient and physician choice, and protect the incumbent’s monopoly in sacral neuromodulation. We are very ...